119 related articles for article (PubMed ID: 12684625)
1. Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Sumi T; Nakatani T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Nakagawa E; Sugimura K; Kawashima H; Ishiko O
Oncol Rep; 2003; 10(3):567-70. PubMed ID: 12684625
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
[TBL] [Abstract][Full Text] [Related]
3. Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.
Kamiya N; Kishimoto T; Suzuki H; Sekita N; Nagai Y; Oosumi N; Kito H; Tochigi N; Shinbo M; Nemori R; Ichikawa T; Igarashi T; Ito H; Ishikura H
Int J Cancer; 2003 Sep; 106(4):480-485. PubMed ID: 12845641
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma.
Takahashi M; Oka N; Naroda T; Nishitani MA; Kanda K; Kanayama HO; Kagawa S
Int J Urol; 2002 Oct; 9(10):531-8. PubMed ID: 12445230
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis.
Liu Q; Zhang GW; Zhu CY; Wei JX; Tian X; Li Y; Li XD
Cancer Biomark; 2016; 16(2):281-9. PubMed ID: 26756619
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
8. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases.
Harada K; Sakai I; Ishimura T; Inoue TA; Hara I; Miyake H
Urol Oncol; 2006; 24(3):201-6. PubMed ID: 16678049
[TBL] [Abstract][Full Text] [Related]
9. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P
Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Yoshida H; Sumi T; Hyun Y; Nakagawa E; Hattori K; Yasui T; Morimura M; Honda K; Nakatani T; Ishiko O
Oncol Rep; 2003; 10(1):45-9. PubMed ID: 12469143
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Significance of Matrix Metalloproteinase-2 Protein Expression in Renal Cell Carcinoma Patients.
Cheng HP; Duan YR; Li Y; Li XD; Zhu CY; Chen BP
Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):353-63. PubMed ID: 26860011
[TBL] [Abstract][Full Text] [Related]
12. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
13. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Jung K
Cancer Sci; 2008 Jun; 99(6):1188-94. PubMed ID: 18422740
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.
Petrella BL; Brinckerhoff CE
Mol Cancer; 2006 Dec; 5():66. PubMed ID: 17140440
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
16. MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1.
Kominsky SL; Doucet M; Thorpe M; Weber KL
Clin Exp Metastasis; 2008; 25(8):865-70. PubMed ID: 18709334
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
Zhang Y; Wu XH; Cao GH; Li S
Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
[TBL] [Abstract][Full Text] [Related]
19. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma.
Abe H; Kamai T; Shirataki H; Oyama T; Arai K; Yoshida K
Int J Cancer; 2008 May; 122(10):2391-7. PubMed ID: 18241036
[TBL] [Abstract][Full Text] [Related]
20. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]